Robert Neville, DPM
Foot Surgery · The Woodlands, TXNPI 1023052974
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (40.4%), travel and lodging and education — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Treace Medical Concepts, Inc. at 44.9% of the total. Reporting peaked in 2019 at $2,246 and has fallen 53.0% since, to $1,057 in 2025.
Across 63 payments — averaging $111.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Treace Medical Concepts, Inc.$3K
- Pylant Medical$1K
- Medinc Of Texas$951
- Stryker$761
- Organogenesis Inc.$357
- Alafair Biosciences, Inc.$250
- plus $440 from 9 others
What the payments were for
- Speaking & faculty fees$120%
- Travel & lodging$2,11230%
- Food & beverage$2,83540%
- Education$2,06629%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Treace Medical Concepts, Inc. | 33 | $3,151 |
| Pylant Medical | 1 | $1,115 |
| Medinc Of Texas | 1 | $951 |
| Stryker | 15 | $761 |
| Organogenesis Inc. | 3 | $357 |
| Alafair Biosciences, Inc. | 1 | $250 |
| Amgen | 1 | $125 |
| Bone Support Inc. | 1 | $92 |
| Abbott | 1 | $80 |
| Melinta Therapeutics, LLC | 1 | $35 |
| Ossio Inc | 1 | $32 |
| Arthrosurface Incorporated | 1 | $25 |
| Paratek Pharmaceuticals, Inc. | 1 | $24 |
| Integra Lifesciences Corporation | 1 | $14 |
| Merck | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapiplasty System$1,846
- Lapiplasty$798
- RAYOS$375
- VersaWrap$250
- AUGMENT INJECTABLE$219
- PuraPly$182
- ACTISHIELD CF$123
- NuShield$119
How this compares
$7,025 in reported general payments places this provider in the 70th percentile of 71 foot surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nabumetone | 335 | $4,199 |
| Gabapentin | 179 | $1,524 |
| Celecoxib | 38 | $1,180 |
| Methylprednisolone | 123 | $633 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 68 | $552 |
| Tramadol Hcl | 149 | $401 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 21 | $137 |
Paid to pharmacies, not to this prescriber.
Other foot surgery in The Woodlands
- Marque AllenSan Antonio$204K
- James JacobsKaty$81K
- Lawrence LaverySan Antonio$59K
- Robert GraserBoerne$54K
- Richard KehSan Antonio$17K
- Chad ClauseWebster$17K
- Seth AshrafSan Antonio$17K
- Kris FordSan Antonio$15K
- Fernando CruzCorsicana$12K
- Richard GalperinDallas$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.